2-Methyl-4-phenyl-buttersaeure-amid | 15118-55-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Methyl-4-phenyl-buttersaeure-amid
• 英文别名: 2-methyl-4-phenyl-butyric acid amide；beta-Phenylethylpropionamide；2-methyl-4-phenylbutanamide
• CAS: 15118-55-5
• 化学式: C₁₁H₁₅NO
• 分子量: 177.246
• InChiKey: UBWWKWFLWOAAAE-UHFFFAOYSA-N

物化性质

• 沸点：
  353.0±21.0 °C(predicted)
• 密度：
  1.024±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  异丁基苯基酮 在 ammonium polysulfide solution 作用下， 生成 2-Methyl-4-phenyl-buttersaeure-amid
  参考文献：
  名称：

  Studies on the Willgerodt Reaction. II. The Mechanism of the Reaction

  摘要：

  DOI：

  10.1021/ja01208a030

文献信息

• [EN] SOMATOSTATIN RECEPTOR 1 AND/OR 4 SELECTIVE AGONISTS AND ANTAGONISTS<br/>[FR] RECEPTEUR 1 ET/OU 4 DE SOMATOSTATINE, AGONISTES ET ANTAGONISTES SELECTIFS
  申请人：JUVANTIA PHARMA LTD OY

  公开号：WO2005033068A1

  公开（公告）日：2005-04-14

  The invention relates to (hetero)arylsulfonylamino based peptidomimetics of formula (I), wherein R1, R3, A, B, D, Q, h and j are defined as disclosed, or a pharmaceutically acceptable salt or ester thereof. Compounds of formula (I) possess high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and/or SSTR4 and can be used for the treatment or diagnosis of diseases or conditions wherein an interaction with SSTR1 and/or SSTR4 is indicated to be useful.

  这项发明涉及基于(杂)芳基磺酰胺的公式(I)的肽类模拟物，其中R1、R3、A、B、D、Q、h和j的定义如所披露的，或其药学上可接受的盐或酯。公式(I)的化合物具有对生长抑素受体亚型SSTR1和/或SSTR4的高亲和力和选择性，并可用于治疗或诊断需要与SSTR1和/或SSTR4相互作用的疾病或病况。
• [EN] HETEROCYCLIC COMPOUNDS AS CLASS II PHOSPHOINOSITIDE 3-KINASE INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES EN TANT QU'INHIBITEURS DE PHOSPHOINOSITIDE 3-KINASE DE CLASSE II
  申请人：FORSCHUNGSVERBUND BERLIN EV

  公开号：WO2019234237A1

  公开（公告）日：2019-12-12

  The present application relates to compounds of formula (1) and their use as medicament, in particular for the treatment of a medical condition associated with defective PI3K signalling.

  本申请涉及式（1）化合物及其作为药物的用途，特别是用于治疗与缺陷PI3K信号传导相关的医疗状况。
• [EN] AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE<br/>[FR] COMPOSÉS AMINO HÉTÉROARYLES COMME MODULATEURS DE LA BÊTA-SECRÉTASE ET PROCÉDÉS D'UTILISATION
  申请人：AMGEN INC

  公开号：WO2011063233A1

  公开（公告）日：2011-05-26

  The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I wherein ring A, B1, B2, B3, L, R1, R4, R5 and m of Formula I are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease (AD), cognitive deficits, cognitive impairment, schizophrenia and other central nervous system conditions related to and/or caused by the formation and/or deposition of plaque on the brain. The invention also comprises further embodiments of Formula I, intermediates and processes useful for the preparation of compounds of Formula I.

  本发明涵盖了一类新化合物，用于调节β-分泌酶酶活性，治疗由β-分泌酶介导的疾病，包括阿尔茨海默病（AD）和相关疾病。在一个实施例中，这些化合物具有一般的化学式I，其中化合物I的环A、B1、B2、B3、L、R1、R4、R5和m在此定义。该发明还包括将这些化合物用于制备药物组合物，用于治疗与β-分泌酶蛋白活性相关的疾病和症状，包括例如阿尔茨海默病（AD）、认知缺陷、认知损害、精神分裂症和其他与大脑斑块形成和/或沉积有关和/或由此引起的中枢神经系统疾病。该发明还包括化合物I的进一步实施例、中间体和用于制备化合物I的过程。
• [EN] HETEROCYCLIC APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF<br/>[FR] AGONISTES DU RÉCEPTEUR DE L'APÉLINE (APJ) HÉTÉROCYCLIQUE ET LEURS UTILISATIONS
  申请人：RES TRIANGLE INST

  公开号：WO2018071526A1

  公开（公告）日：2018-04-19

  This disclosure is directed to agonists of the apelin receptor (APJ) with heterocyclic cores and uses of such agonists.

  这项披露涉及具有杂环核的Aplin受体（APJ）激动剂以及这些激动剂的用途。
• ALPHA HELIX MIMETICS AND METHODS RELATING THERETO
  申请人：Odagami Takenao

  公开号：US20120088770A1

  公开（公告）日：2012-04-12

  Alpha-helix mimetic structures and compounds represented by the formula (I) wherein the general formula and the definition of each symbol are as defined in the specification, a chemical library relating thereto, and methods relating thereto, are disclosed. Applications of these compounds in the treatment of medical conditions, e.g., cancer diseases, fibrotic diseases, and pharmaceutical compositions comprising the mimetics are further disclosed.

  本文披露了代表公式(I)的α-螺旋类似物结构和化合物，其中一般公式和每个符号的定义如规范所定义，以及与之相关的化学库和方法。此外，还披露了这些化合物在治疗医疗状况（例如癌症疾病、纤维化疾病）方面的应用，以及包括类似物的制药组合物。